Mytil 4 mg Syrup is for oral administration. It can be taken with or without food. Use a measuring spoon or cup for accurate dosing, especially for children.

Cyproheptadine is a first-generation antihistamine with anticholinergic, antiserotonergic, and local anesthetic properties. It competitively blocks H1 histamine receptors, thereby reducing the effects of histamine in allergic reactions. Its appetite-stimulating effect is believed to be due to its antagonism of serotonin receptors (5-HT2A, 5-HT2C) in the hypothalamus.

• •Hypersensitivity to Cyproheptadine or any component of the formulation.
• •Newborn or premature infants.
• •Nursing mothers.
• •Patients with angle-closure glaucoma, urinary retention, prostatic hypertrophy, or stenosing peptic ulcer.
• •Elderly or debilitated patients.

Store at room temperature (below 30°C), protected from light and moisture. Keep out of reach of children.

Symptoms of overdose may include drowsiness, dizziness, ataxia, dry mouth, fixed dilated pupils, flushing, gastrointestinal symptoms, and in severe cases, central nervous system depression or excitation. Management involves symptomatic and supportive treatment, including gastric lavage, activated charcoal, and monitoring vital signs.

Pregnancy Category B. Use only if clearly needed. Contraindicated in nursing mothers as it may be excreted in breast milk and cause adverse effects in infants.